Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 1
1952 1
1953 1
1956 1
1957 1
1958 1
1959 2
1965 1
1966 2
1967 2
1970 3
1971 2
1974 1
1975 1
1976 2
1977 1
1978 3
1979 1
1980 2
1981 1
1982 1
1984 3
1985 3
1986 3
1987 7
1988 3
1989 1
1990 4
1991 6
1992 6
1995 2
1996 2
1997 1
1998 1
1999 2
2000 3
2001 2
2002 4
2003 2
2004 5
2005 8
2006 3
2007 6
2008 11
2009 5
2010 5
2011 11
2012 24
2013 29
2014 16
2015 18
2016 25
2017 18
2018 11
2019 13
2020 9
2021 7
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Results by year
Filters applied: . Clear all
Page 1
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.
Chan JCN, Lim LL, Wareham NJ, Shaw JE, Orchard TJ, Zhang P, Lau ESH, Eliasson B, Kong APS, Ezzati M, Aguilar-Salinas CA, McGill M, Levitt NS, Ning G, So WY, Adams J, Bracco P, Forouhi NG, Gregory GA, Guo J, Hua X, Klatman EL, Magliano DJ, Ng BP, Ogilvie D, Panter J, Pavkov M, Shao H, Unwin N, White M, Wou C, Ma RCW, Schmidt MI, Ramachandran A, Seino Y, Bennett PH, Oldenburg B, Gagliardino JJ, Luk AOY, Clarke PM, Ogle GD, Davies MJ, Holman RR, Gregg EW. Chan JCN, et al. Among authors: ogilvie d. Lancet. 2021 Dec 19;396(10267):2019-2082. doi: 10.1016/S0140-6736(20)32374-6. Epub 2020 Nov 12. Lancet. 2021. PMID: 33189186 Review. No abstract available.
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.
Pappalardi MB, Keenan K, Cockerill M, Kellner WA, Stowell A, Sherk C, Wong K, Pathuri S, Briand J, Steidel M, Chapman P, Groy A, Wiseman AK, McHugh CF, Campobasso N, Graves AP, Fairweather E, Werner T, Raoof A, Butlin RJ, Rueda L, Horton JR, Fosbenner DT, Zhang C, Handler JL, Muliaditan M, Mebrahtu M, Jaworski JP, McNulty DE, Burt C, Eberl HC, Taylor AN, Ho T, Merrihew S, Foley SW, Rutkowska A, Li M, Romeril SP, Goldberg K, Zhang X, Kershaw CS, Bantscheff M, Jurewicz AJ, Minthorn E, Grandi P, Patel M, Benowitz AB, Mohammad HP, Gilmartin AG, Prinjha RK, Ogilvie D, Carpenter C, Heerding D, Baylin SB, Jones PA, Cheng X, King BW, Luengo JI, Jordan AM, Waddell I, Kruger RG, McCabe MT. Pappalardi MB, et al. Among authors: ogilvie d. Nat Cancer. 2021 Oct;2(10):1002-1017. Epub 2021 Sep 27. Nat Cancer. 2021. PMID: 34790902 Free PMC article.
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.
Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, James DI, Guerrero Llobet S, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andújar-Sánchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S. Gogola E, et al. Among authors: ogilvie dj. Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008. Cancer Cell. 2018. PMID: 29894693 Free article.
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.
Pillay N, Tighe A, Nelson L, Littler S, Coulson-Gilmer C, Bah N, Golder A, Bakker B, Spierings DCJ, James DI, Smith KM, Jordan AM, Morgan RD, Ogilvie DJ, Foijer F, Jackson DA, Taylor SS. Pillay N, et al. Among authors: ogilvie dj. Cancer Cell. 2019 Mar 18;35(3):519-533.e8. doi: 10.1016/j.ccell.2019.02.004. Cancer Cell. 2019. PMID: 30889383 Free PMC article.
Pseudohypoaldosteronism.
Dillon MJ, Leonard JV, Buckler JM, Ogilvie D, Lillystone D, Honour JW, Shackleton CH. Dillon MJ, et al. Among authors: ogilvie d. Arch Dis Child. 1980 Jun;55(6):427-34. doi: 10.1136/adc.55.6.427. Arch Dis Child. 1980. PMID: 7002056 Free PMC article.
Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.
Davies BR, Greenwood H, Dudley P, Crafter C, Yu DH, Zhang J, Li J, Gao B, Ji Q, Maynard J, Ricketts SA, Cross D, Cosulich S, Chresta CC, Page K, Yates J, Lane C, Watson R, Luke R, Ogilvie D, Pass M. Davies BR, et al. Among authors: ogilvie d. Mol Cancer Ther. 2012 Apr;11(4):873-87. doi: 10.1158/1535-7163.MCT-11-0824-T. Epub 2012 Jan 31. Mol Cancer Ther. 2012. PMID: 22294718 Clinical Trial.
Prenatal diagnosis in osteogenesis imperfecta.
Sykes B, Ogilvie D. Sykes B, et al. Among authors: ogilvie d. Ann N Y Acad Sci. 1988;543:136-41. doi: 10.1111/j.1749-6632.1988.tb55326.x. Ann N Y Acad Sci. 1988. PMID: 3063160 Review. No abstract available.
Interventions to promote cycling: systematic review.
Yang L, Sahlqvist S, McMinn A, Griffin SJ, Ogilvie D. Yang L, et al. Among authors: ogilvie d. BMJ. 2010 Oct 18;341:c5293. doi: 10.1136/bmj.c5293. BMJ. 2010. PMID: 20959282 Free PMC article. Review.
Interventions to promote walking: systematic review.
Ogilvie D, Foster CE, Rothnie H, Cavill N, Hamilton V, Fitzsimons CF, Mutrie N; Scottish Physical Activity Research Collaboration. Ogilvie D, et al. BMJ. 2007 Jun 9;334(7605):1204. doi: 10.1136/bmj.39198.722720.BE. Epub 2007 May 31. BMJ. 2007. PMID: 17540909 Free PMC article. Review.
295 results